TCM
BSX icon

Tufton Capital Management’s Boston Scientific BSX Stock Holding History

Tufton Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$372K Sell
8,727
-350
-4% -$19K 0.06% 104
2026
Q1 		$569K Sell
9,077
-100
-1% -$8K 0.1% 92
2025
Q4 		$875K Sell
9,177
-1,039
-10% -$102K 0.15% 78
2025
Q3 		$997K Sell
10,216
-110
-1% -$11.4K 0.18% 76
2025
Q2 		$1.11M Hold
10,326
– – 0.21% 72
2025
Q1 		$1.04M Sell
10,326
-427
-4% -$43K 0.2% 74
2024
Q4 		$960K Hold
10,753
– – 0.18% 76
2024
Q3 		$901K Sell
10,753
-589
-5% -$46.4K 0.17% 76
2024
Q2 		$873K Buy
11,342
+77
+0.7% +$5.64K 0.17% 79
2024
Q1 		$772K Hold
11,265
– – 0.15% 80
2023
Q4 		$651K Sell
11,265
-10
-0.1% -$534 0.14% 82
2023
Q3 		$595K Buy
11,275
+185
+2% +$9.7K 0.13% 81
2023
Q2 		$600K Sell
11,090
-4,000
-27% -$209K 0.13% 83
2023
Q1 		$755K Sell
15,090
-50
-0.3% -$2.36K 0.16% 76
2022
Q4 		$701K Hold
15,140
– – 0.15% 75
2022
Q3 		$586K Buy
15,140
+120
+0.8% +$4.81K 0.14% 84
2022
Q2 		$559K Buy
15,020
+325
+2% +$13.2K 0.1% 85
2022
Q1 		$650K Buy
14,695
+275
+2% +$11.9K 0.11% 83
2021
Q4 		$612K Buy
14,420
+375
+3% +$15.8K 0.09% 88
2021
Q3 		$609K Buy
14,045
+150
+1% +$6.64K 0.1% 87
2021
Q2 		$594K Buy
13,895
+4,325
+45% +$182K 0.1% 88
2021
Q1 		$369K Buy
+9,570
New +$362K 0.06% 104

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
MF
Milford Funds Auckland $6.14B AUM
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Tufton Capital Management's BSX Position: Q2 2026 in Review

Tufton Capital Management reduced its Boston Scientific (BSX) stake by 3.9% in Q2 2026, selling an estimated $19K and leaving 8,727 shares worth $372K. The position accounts for 0.06% of the portfolio, ranked #104.

Tufton Capital Management first reported a position in BSX in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.11M in Q2 2025. 534 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Tufton Capital Management held 8,727 shares of Boston Scientific worth $372K as of Q2 2026.
  • Tufton Capital Management sold 350 Boston Scientific shares in Q2 2026, an estimated $19K.
  • Boston Scientific made up 0.06% of Tufton Capital Management's portfolio in Q2 2026, its #104 holding.
  • Tufton Capital Management first reported a position in Boston Scientific in Q1 2021 and has held it in 22 quarters since.
  • Tufton Capital Management's Boston Scientific position peaked at $1.11M in Q2 2025.
  • 534 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Tufton Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.